Let's look at three no-brainer stocks that are all behemoths in their respective industries. Two of them have market caps ...

This article is for CEOs, investors, and HR folks outside the US who want to get into or grow in the US biotech world. We'll ...

One of my retirement investing platforms happens to be Fidelity, so I’ve been diving deeper into which exchange traded funds ...

Billionaires Michael and Susan Dell pledged a historic $6.25 billion on Tuesday to provide an incentive to families to adopt ...

The economy and the stock market are at a breaking point. Here's what to do, depending on your age. Stock-market booms always end the same way: Optimism outruns reality, then prices correct. Investing ...

The fund-raising effort, the company’s third this year, values it at $11 billion, and comes amid stiff competition in the ...

Explore the sustainability of the current AI-driven stock market rally and learn why pure-play AI firms like CoreWeave may ...

Pfizer is launching seven phase 3 studies for PF-4044 soon and plans to initiate an additional 10 (at least) by the end of ...

SES could make early investors millionaires because of its recent good news. The company has revised its revenue guidance ...

Diversification and high-quality assets can outperform S&P 500 funds. Read the investment strategies I recommend for the ...

So, between XRP and bitcoin at these knife-edge supports and Nasdaq’s uneasy top signals, traders have a lot on their plates.

From corporate executives to Wall Street analysts to Federal Reserve officials, references to the “K-shaped economy” are ...